<i>Leishmania</i>’nın Proteom Profilinde Hekzokinaz İfadesi
PDF
Atıf
Paylaş
Talep
P: 83-87
Haziran 2021

Leishmania’nın Proteom Profilinde Hekzokinaz İfadesi

Turkiye Parazitol Derg 2021;45(2):83-87
Bilgi mevcut değil.
Bilgi mevcut değil
Alındığı Tarih: 31.10.2020
Kabul Tarihi: 11.11.2020
Yayın Tarihi: 07.06.2021
PDF
Atıf
Paylaş
Talep

ÖZET

Amaç:

İlaç direnci ile hekzokinaz (HK) ekspresyonu arasındaki ilişki leishmaniasiste gösterilmiştir. Bu çalışmada, İran’da Crithidia ile enfekte olan kutanöz leishmaniasis (KL) ile takipli hastalarda uzun tedavi süresine göre, HK’nin Leishmania major proteomunda gösterilmesi ve Crithidia’nın proteomik bir yaklaşım kullanarak ekspresyonunun araştırılması amaçlanmıştır.

Yöntemler:

Polimeraz zincir reaksiyonu (PZR) kullanılarak L. major ve Crithidia'nın karakterizasyonu için İran'ın Fars ilindeki 205 hastadan lezyon örnekleri toplanmıştır. Protein ekstraksiyonundan sonra protein ayrılması için iki boyutlu jel elektroforezi kullanıldı. MALDI TOF/TOF MS kullanılarak L. major ve Crithidia proteomunda HK’yi bulmak için birkaç nokta izole edildi.

Bulgular:

PCR sonuçlarına göre Crithidia pozitif 5 olgu ve L. major pozitif olan 96 olgu mevcuttu. MALDI TOF/TOF MS, HK’yi L. major ve Crithidia proteomunda ortak bir protein olarak ortaya koymaktadır. HK, Crithidia proteomunda L. major proteom ile karşılaştırıldığında yukarı doğru düzenlenmiştir.

Sonuç:

Leishmaniaziste HK ekspresyonu ve ilaç direnci ilişkisi gösterildiğinden, Crithidia’da HK’nin aşırı ekspresyonu, Crithidia ile birlikte enfekte olan KL hastalarında tedavi süresinin artmasıyla ilişkili olabilir.

References

1
Georgiadou SP, Makaritsis KP, Dalekos GN. Leishmaniasis revisited: Current aspects on epidemiology, diagnosis and treatment. J Transl Int Med 2015; 3: 43-50. 
2
Kermanjani A, Akhlaghi L, Oormazdi H, Hadighi R. Isolation and identification of cutaneous leishmaniasis species by PCR-RFLP in Ilam province, the west of Iran. J Parasit Dis 2017; 41: 175-9. 
3
Alvar J, Vélez ID, Bern C, Herrero M, Desjeux P, Cano J, et al. Leishmaniasis worldwide and global estimates of its incidence. PLoS One 2012; 7: 35671. 
4
Ghobakhloo N, Motazedian MH, Naderi S, Ebrahimi S. Isolation of Crithidia spp. from lesions of immunocompetent patients with suspected cutaneous leishmaniasis in Iran. Trop Med Int Health 2019; 24: 116-6.
5
Wallace FG. The trypanosomatid parasites of insects and arachnids. Exp Parasitol 1966; 18: 124-93. 
6
Doudi M, Karami M, Eslami G, Setorki M. A study of genetic polymorphism of Crithidia in Isfahan, Iran. Zahedan J Res Med Sci 2015; 17: 971.
7
Doudi M, Setorki M, Bidabadi LS. Genotyping of isolated cutaneous leishmaniasis species by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis in endemic foci of Isfahan, Iran. AJMR 2011; 5; 4607-14.
8
Eslami G, Salehi R, Khosravi S, Doudi M. Genetic analysis of clinical isolates of Leishmania major from Isfahan, Iran. J Vector Borne Dis 2012; 49: 168-74. 
9
Rashidi S, Mojtahedi Z, Shahriari B, Kalantar K, Ghalamfarsa G, Mohebali M, et al. An immunoproteomic approach to identifying immunoreactive proteins in Leishmania infantum amastigotes using sera of dogs infected with canine visceral leishmaniasis. Pathog Glob Health 2019; 113: 124-32. 
10
Singh S, Dubey VK. Quantitative Proteome Analysis of Leishmania donovani under Spermidine Starvation. PLoS One 2016; 11: 0154262. 
11
Alcolea PJ, Alonso A, García-Tabares F, Toraño A, Larraga V. An Insight into the proteome of Crithidia fasciculata choanomastigotes as a comparative approach to axenic growth, peanut lectin agglutination and differentiation of Leishmania spp. promastigotes. PLoS One 2014; 9: 113837.
12
de Cássia-Pires R, de Melo MF, Barbosa RD, Roque AL. Multiplex PCR as a tool for the diagnosis of Leishmania spp. kDNA and the gapdh housekeeping gene of mammal hosts. PLoS One 2017; 12: 0173922. 
13
Bresson A, Jorge V, Dowkiw A, Guerin V, Bourgait I, Tuskan GA, et al. Qualitative and quantitative resistances to leaf rust finely mapped within two nucleotide-binding site leucine-rich repeat (NBS-LRR)-rich genomic regions of chromosome 19 in poplar. New Phytol 2011; 192: 151-63. 
14
Brotherton MC, Racine G, Foucher AL, Drummelsmith J, Papadopoulou B, Ouellette M. Analysis of stage-specific expression of basic proteins in Leishmania infantum. J Proteome Res 2010; 9: 3842-53. 
15
Rabilloud T. Silver staining of 2-D electrophoresis gels. Methods Mol Biol 1999; 112: 297-305. 
16
Mojtahedi Z, Clos J, Kamali-Sarvestani E. Leishmania major: identification of developmentally regulated proteins in procyclic and metacyclic promastigotes. Exp Parasitol 2008; 119: 422-9.
17
Barrett J, Brophy PM, Hamilton JV. Analysing proteomic data. Int J Parasitol 2005; 35: 543-53. 
18
Rashidi S, Kalantar K, Hatam G. Using proteomics as a powerful tool to develop a vaccine against Mediterranean visceral leishmaniasis. J Parasit Dis 2018; 42: 162-70. 
19
Harris MT, Mitchell WG, Morris JC. Targeting protozoan parasite metabolism: glycolytic enzymes in the therapeutic crosshairs. Curr Med Chem 2014; 21: 1668-78.
20
Foulquié MR, Louassini M, Castanys S, Gamarro F, Benítez R, Adroher FJ. Different catalytic activities of hexokinase and phosphofructokinase in wild type and glucantime-resistant Leishmania promastigotes appears not causatively related to resistance. Eur J Protistol 1999; 35: 338-41.
21
Mottram JC, Coombs GH. Leishmania mexicana: enzyme activities of amastigotes and promastigotes and their inhibition by antimonials and arsenicals. Exp Parasitol 1985; 59: 151-60. 
22
Pabón MA, Cáceres AJ, Gualdrón M, Quiñones W, Avilán L, Concepción JL. Purification and characterization of hexokinase from Leishmania mexicana. Parasitol Res 2007; 100: 803-10. 
23
Azmi K, Schonian G, Schnur LF, Nasereddin A, Ereqat S, Abdeen Z. Development of assays using hexokinase and phosphoglucomutase gene sequences that distinguish strains of Leishmania tropica from different zymodemes and microsatellite clusters and their application to Palestinian foci of cutaneous leishmaniasis. PLoS Negl Trop Dis 2013; 7: 2464.
2024 ©️ Galenos Publishing House